HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Enforcement In Brief

This article was originally published in The Tan Sheet

Executive Summary

Exec charged in bird flu claim case

You may also be interested in...

NDI Notification Draft Guidance Seminar In Brief

History of use, toxicology studies key

H&P/Triad Stops OTC Manufacturing In Consent Decree With FDA

FDA forbids Triad Group, H&P Industries and three employees from manufacturing or distributing OTC products until they comply with good manufacturing practices.

“Fowl” Play? FDA Warning Letters Target Avian Flu Supplement Marketers

Nine dietary supplement firms who received FDA warning letters for marketing their products as treatments for avian flu could face "far more serious enforcement activity" if they do not take "immediate corrective action," according to an industry lawyer

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts